We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$216M
AUM Growth
+$17.6M
(+8.9%)
Cap. Flow
-$4.87M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
44.96%
Holding
70
New
3
Increased
13
Reduced
28
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MODN
MODEL N, INC.
MODN
|
+$4.66M |
| 2 |
AKRX
Akorn Inc
AKRX
|
+$4.64M |
| 3 |
Option Care Health
OPCH
|
+$4.57M |
| 4 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$3.98M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$8.53M |
| 2 |
AngioDynamics
ANGO
|
+$3.36M |
| 3 |
ELGX
Endologix Inc
ELGX
|
+$3.12M |
| 4 |
Arrowhead Research
ARWR
|
+$2.37M |
| 5 |
Insmed
INSM
|
+$2.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.24% |
| 2 | Energy | 4.55% |
| 3 | Communication Services | 2.46% |
| 4 | Real Estate | 1.52% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.96B
| $16.4M | 7.59% |
2,038,988
-1,064,398
| -34% | -$8.53M |
|
|
AKRX
2
DELISTED
Akorn Inc
AKRX
| $15M | 6.94% |
525,737
+167,212
| +47% | +$4.64M |
|
3
AtriCure
ATRC
$1.92B
| $13M | 6.04% |
922,590
-4,620
| -0.5% | -$70.4K |
|
|
LHCG
4
DELISTED
LHC Group LLC
LHCG
| $9.82M | 4.55% |
226,943
+54,406
| +32% | +$2.22M |
|
|
ENZ
5
DELISTED
Enzo Biochem, Inc.
ENZ
| $8.15M | 3.78% |
1,364,963
-366,823
| -21% | -$2.04M |
|
6
Harvard Bioscience
HBIO
$27.5M
| $7.84M | 3.63% |
274,020
+59,001
| +27% | +$1.88M |
|
|
ENTL
7
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $7.24M | 3.35% |
396,291
-850
| -0.2% | -$14.6K |
|
|
TLGT
8
DELISTED
Teligent, Inc
TLGT
| $7.19M | 3.33% |
100,753
-1,153
| -1% | -$67.1K |
|
|
OXFD
9
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $6.31M | 2.92% |
700,849
+154,125
| +28% | +$1.51M |
|
|
AMED
10
DELISTED
Amedisys
AMED
| $6.1M | 2.82% |
120,778
-26,040
| -18% | -$1.31M |
|
|
NXTM
11
DELISTED
NxStage Medical Inc.
NXTM
| $5.51M | 2.55% |
254,113
-3,814
| -1% | -$68K |
|
12
LeMaitre Vascular
LMAT
$2.32B
| $5.5M | 2.55% |
385,562
-6,755
| -2% | -$103K |
|
13
Orthofix Medical
OFIX
$477M
| $5.5M | 2.55% |
129,745
+44,592
| +52% | +$1.94M |
|
14
HealthStream
HSTM
$819M
| $5.45M | 2.52% |
205,298
+88,730
| +76% | +$2.08M |
|
|
15
Option Care Health
OPCH
$3.45B
| $5.33M | 2.47% |
523,021
+447,493
| +592% | +$4.57M |
|
|
MODN
16
DELISTED
MODEL N, INC.
MODN
| $5.3M | 2.46% |
+397,152
| New | +$4.66M |
|
17
Ligand Pharmaceuticals
LGND
$5.76B
| $5.02M | 2.33% |
67,518
-23,390
| -26% | -$1.74M |
|
|
EVHC
18
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $4.87M | 2.26% |
64,110
-12,896
| -17% | -$916K |
|
|
KTWO
19
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.38M | 2.03% |
+281,975
| New | +$3.98M |
|
|
PETX
20
DELISTED
Aratana Therapeutics, Inc.
PETX
| $4.33M | 2.01% |
684,921
+236,915
| +53% | +$1.52M |
|
|
MDCO
21
DELISTED
Medicines Co
MDCO
| $4.23M | 1.96% |
125,889
+1,149
| +0.9% | +$40.5K |
|
|
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
| $4.16M | 1.93% |
255,163
-109,815
| -30% | -$1.62M |
|
|
LDRH
23
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $3.91M | 1.81% |
105,780
-74,136
| -41% | -$2.1M |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $3.71M | 1.72% |
198,219
-85,001
| -30% | -$1.5M |
|
|
SRGA
25
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.54M | 1.64% |
32,908
-561
| -2% | -$65.7K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, First Light Asset Management held 70 positions worth $216M, up 8.9% from $198M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
First Light Asset Management's Q2 2016 filing shows 3 new, 13 increased, 28 reduced and 5 closed positions. Its largest new stake was MODEL N, INC.: 397,152 shares worth $5.3M. The largest sale was NeoGenomics, an estimated $8.53M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 80% a quarter earlier, followed by Energy and Communication Services.
- First Light Asset Management's largest Q2 2016 buy was MODEL N, INC.: 397,152 shares worth $5.3M.
- First Light Asset Management added most to Akorn Inc in Q2 2016, an estimated $4.64M increase.
- First Light Asset Management's biggest Q2 2016 reduction was NeoGenomics, cutting an estimated $8.53M.
- First Light Asset Management fully exited AngioDynamics in Q2 2016, selling an estimated $3.36M.
- First Light Asset Management's ten largest holdings make up 45% of its $216M portfolio in Q2 2016.
- First Light Asset Management opened 3 new positions and closed 5 in Q2 2016.
- First Light Asset Management's portfolio value rose 8.9% quarter-over-quarter to $216M.
Based on First Light Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.